A recent outbreak of bird flu has revealed a strain in a Texas patient with nine mutations, making it more efficient and deadly. The virus, H5N1, commonly found in wild birds, has now infected mammals ...

Scientists have said that the strain developed changes that make it better at spreading, triggering inflammation, and causing ...

Researchers at Texas Biomed have identified nine mutations in a strain of bird flu found in a person in Texas. Bad news: This ...

As payment comes in for the gift, college staff will notify the Division of Advancement & Alumni’s System Compliance and Gift Management department to intercept the payment and begin the TRIP Match ...

In a new study, researchers at University of Iowa Health Care and colleagues at Texas Biomedical Research Institute and Boston University, have traced a cellular route the virus uses to traverse ...

A live-attenuated vaccine under development is safe and 100% effective against Lassa virus in preclinical studies. A vaccine candidate against Lassa virus completely protected guinea pigs exposed ...

Credit: Nick Wagner / San Antonio Report UTSA is moving forward with plans to temporarily house the Institute of Texan Cultures at Frost ... The museum paused operations in the Texas State Exhibits ...

A vaccine candidate against Lassa virus completely protected guinea pigs exposed to an otherwise lethal dose of the virus, researchers from Texas Biomedical Research Institute (Texas Biomed), The ...

Our research is aimed at understanding the molecular and cellular processes underlying human health and disease with a key aim to translate this research into diagnostic and therapeutic applications.

Texas Biomedical Research Institute (Texas Biomed), located in San Antonio, Texas, is an independent biomedical research institution, specializing in genetics and in virology and immunology.

Texas Biomed Professor Luis Martínez-Sobrido, Ph.D., and Scripps Research Institute Professor Juan Carlos de la Torre, Ph.D., have been working on a Lassa virus vaccine candidate for the past 10 ...

The Friedrich Miescher Institute for Biomedical Research (FMI) is part of the Novartis Research Foundation and is a world-class center for basic research in life sciences based in Basel, Switzerland.